Frontiers in Oncology (Oct 2022)
Corrigendum: RAB42 promotes glioma pathogenesis via the VEGF signaling pathway
- Baoling Liu,
- Quanping Su,
- Bolian Xiao,
- Guodong Zheng,
- Lizhong Zhang,
- Jiawei Yin,
- Lijuan Wang,
- Lijuan Wang,
- Fengyuan Che,
- Fengyuan Che,
- Xueyuan Heng
Affiliations
- Baoling Liu
- Central Laboratory, Key Laboratory of Tumor Biology, Key Laboratory of Neurophysiology, Linyi People’s Hospital, Linyi, China
- Quanping Su
- Central Laboratory, Key Laboratory of Tumor Biology, Key Laboratory of Neurophysiology, Linyi People’s Hospital, Linyi, China
- Bolian Xiao
- Central Laboratory, Key Laboratory of Tumor Biology, Key Laboratory of Neurophysiology, Linyi People’s Hospital, Linyi, China
- Guodong Zheng
- Department of Neurosurgery, Linyi People’s Hospital, Linyi, China
- Lizhong Zhang
- Neuropathological laboratory, Linyi People’s Hospital, Linyi, China
- Jiawei Yin
- Central Laboratory, Key Laboratory of Tumor Biology, Key Laboratory of Neurophysiology, Linyi People’s Hospital, Linyi, China
- Lijuan Wang
- Central Laboratory, Key Laboratory of Tumor Biology, Key Laboratory of Neurophysiology, Linyi People’s Hospital, Linyi, China
- Lijuan Wang
- Department of Hematology, Linyi People’s Hospital, Linyi, China
- Fengyuan Che
- Central Laboratory, Key Laboratory of Tumor Biology, Key Laboratory of Neurophysiology, Linyi People’s Hospital, Linyi, China
- Fengyuan Che
- Department of Neurology, Linyi People’s Hospital, Linyi, China
- Xueyuan Heng
- Department of Neurosurgery, Linyi People’s Hospital, Linyi, China
- DOI
- https://doi.org/10.3389/fonc.2022.1034167
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
